multiplex immunohistochemistry Search Results


5-color, multiplex immunohistochemistry  (Indivumed gmbh)
90
Indivumed gmbh 5-color, multiplex immunohistochemistry
5 Color, Multiplex Immunohistochemistry, supplied by Indivumed gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/5+color++multiplex+immunohistochemistry/pm37087488-121-8-13
Average 90 stars, based on 1 article reviews
5-color, multiplex immunohistochemistry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
whole mount rna multiplexed in situ hybridization chain reaction with immunohistochemistry, clearing and imaging  (KU Leuven)
90
KU Leuven whole mount rna multiplexed in situ hybridization chain reaction with immunohistochemistry, clearing and imaging
Whole Mount Rna Multiplexed In Situ Hybridization Chain Reaction With Immunohistochemistry, Clearing And Imaging, supplied by KU Leuven, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/whole+mount+rna+multiplexed+in+situ+hybridization+chain+reaction+with+immunohistochemistry++clearing+and+imaging/pm35711315-10-12-42
Average 90 stars, based on 1 article reviews
whole mount rna multiplexed in situ hybridization chain reaction with immunohistochemistry, clearing and imaging - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
multiplex immunohistochemistry mihc  (Spatial Transcriptomics Inc)
86
Spatial Transcriptomics Inc multiplex immunohistochemistry mihc
(A) , <t>mIHC</t> showing the localization of SPOCK1+ CAF cells and tumor cells in breast cancer tissues; (B-E) , mIHC plots showing the marker proteins; (F) , positive correlation trend between ANXA2 and SPOCK1 in TCGA; (G) , knockdown of ANXA2 from human breast cancer fibroblasts (CP-H172) resulted in reduction of both SPOCK and IGF1.
Multiplex Immunohistochemistry Mihc, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/immunohistochemistry+mihc+multiplex/pmc12361150-188-3-0
Average 86 stars, based on 1 article reviews
multiplex immunohistochemistry mihc - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
multiplex immunohistochemistry  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare multiplex immunohistochemistry
(A) , <t>mIHC</t> showing the localization of SPOCK1+ CAF cells and tumor cells in breast cancer tissues; (B-E) , mIHC plots showing the marker proteins; (F) , positive correlation trend between ANXA2 and SPOCK1 in TCGA; (G) , knockdown of ANXA2 from human breast cancer fibroblasts (CP-H172) resulted in reduction of both SPOCK and IGF1.
Multiplex Immunohistochemistry, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/multiplex+immunohistochemistry/pm27181388-36-26-7
Average 90 stars, based on 1 article reviews
multiplex immunohistochemistry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
multiplex immunohistochemistry  (IonPath Inc)
90
IonPath Inc multiplex immunohistochemistry
(A) , <t>mIHC</t> showing the localization of SPOCK1+ CAF cells and tumor cells in breast cancer tissues; (B-E) , mIHC plots showing the marker proteins; (F) , positive correlation trend between ANXA2 and SPOCK1 in TCGA; (G) , knockdown of ANXA2 from human breast cancer fibroblasts (CP-H172) resulted in reduction of both SPOCK and IGF1.
Multiplex Immunohistochemistry, supplied by IonPath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/multiplex+immunohistochemistry/pm32203152-21-7-14
Average 90 stars, based on 1 article reviews
multiplex immunohistochemistry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cyclic multiplex immunohistochemistry mxihc  (Wolters Kluwer Health)
86
Wolters Kluwer Health cyclic multiplex immunohistochemistry mxihc
(A) , <t>mIHC</t> showing the localization of SPOCK1+ CAF cells and tumor cells in breast cancer tissues; (B-E) , mIHC plots showing the marker proteins; (F) , positive correlation trend between ANXA2 and SPOCK1 in TCGA; (G) , knockdown of ANXA2 from human breast cancer fibroblasts (CP-H172) resulted in reduction of both SPOCK and IGF1.
Cyclic Multiplex Immunohistochemistry Mxihc, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/cyclic+immunohistochemistry+multiplex+mxihc/10__1097_slash_lgt__0000000000000845-355-0-12
Average 86 stars, based on 1 article reviews
cyclic multiplex immunohistochemistry mxihc - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
multiplex immunohistochemistry  (Radboud University)
86
Radboud University multiplex immunohistochemistry
(A) , <t>mIHC</t> showing the localization of SPOCK1+ CAF cells and tumor cells in breast cancer tissues; (B-E) , mIHC plots showing the marker proteins; (F) , positive correlation trend between ANXA2 and SPOCK1 in TCGA; (G) , knockdown of ANXA2 from human breast cancer fibroblasts (CP-H172) resulted in reduction of both SPOCK and IGF1.
Multiplex Immunohistochemistry, supplied by Radboud University, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/immunohistochemistry+multiplex/pm41786454-307-13-6
Average 86 stars, based on 1 article reviews
multiplex immunohistochemistry - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
fluorescent multiplex immunohistochemistry mihc analysis  (Servicebio Inc)
86
Servicebio Inc fluorescent multiplex immunohistochemistry mihc analysis
(A) , <t>mIHC</t> showing the localization of SPOCK1+ CAF cells and tumor cells in breast cancer tissues; (B-E) , mIHC plots showing the marker proteins; (F) , positive correlation trend between ANXA2 and SPOCK1 in TCGA; (G) , knockdown of ANXA2 from human breast cancer fibroblasts (CP-H172) resulted in reduction of both SPOCK and IGF1.
Fluorescent Multiplex Immunohistochemistry Mihc Analysis, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/analysis+fluorescent+immunohistochemistry+mihc+multiplex/pm41353296-268-18-35
Average 86 stars, based on 1 article reviews
fluorescent multiplex immunohistochemistry mihc analysis - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
multiplex immunohistochemistry ihc  (Veracyte Inc)
86
Veracyte Inc multiplex immunohistochemistry ihc
Pharmacodynamic effects of combination treatment (Sym021+S095018) on immune-related markers. ( A ) Total soluble TIM3 concentration (nM) over time in serum as a target engagement biomarker (N=30). ( B ) CD8 T-cell density, antigen processing and cytotoxicity gene signatures at baseline and EOC1 (N=19). ( C ) <t>IHC</t> and transcriptomic profiling biomarker changes on treatment (N=19). ( D ) IHC and transcriptomic profiling biomarker assessment at screening (N=25). Ag, antigen; BOR, best overall response; CPS, combined positive score; EOC1, end of cycle 1; IHC, <t>immunohistochemistry;</t> PD, progressive disease; PR, partial response; SD, stable disease; TIM-3, T-cell immunoglobulin and mucin-domain containing 3; TIS, tumor inflammation signature; TLS, tertiary lymphoid structure.
Multiplex Immunohistochemistry Ihc, supplied by Veracyte Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+immunohistochemistry/ihc+immunohistochemistry+multiplex/pmc12993298-144-7-5
Average 86 stars, based on 1 article reviews
multiplex immunohistochemistry ihc - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


(A) , mIHC showing the localization of SPOCK1+ CAF cells and tumor cells in breast cancer tissues; (B-E) , mIHC plots showing the marker proteins; (F) , positive correlation trend between ANXA2 and SPOCK1 in TCGA; (G) , knockdown of ANXA2 from human breast cancer fibroblasts (CP-H172) resulted in reduction of both SPOCK and IGF1.

Journal: Frontiers in Oncology

Article Title: SPOCK1 promotes the progression of breast cancer by modulating cancer-associated fibroblasts and exerts a synergistic effect with ANXA2

doi: 10.3389/fonc.2025.1619171

Figure Lengend Snippet: (A) , mIHC showing the localization of SPOCK1+ CAF cells and tumor cells in breast cancer tissues; (B-E) , mIHC plots showing the marker proteins; (F) , positive correlation trend between ANXA2 and SPOCK1 in TCGA; (G) , knockdown of ANXA2 from human breast cancer fibroblasts (CP-H172) resulted in reduction of both SPOCK and IGF1.

Article Snippet: Spatial transcriptomics and multiplex immunohistochemistry (mIHC) further validated the spatial co-localization of SPOCK1 + CAFs and malignant epithelial cells in the tumor core, reinforcing the spatial-functional link between stromal and tumor cells.

Techniques: Marker, Knockdown

Pharmacodynamic effects of combination treatment (Sym021+S095018) on immune-related markers. ( A ) Total soluble TIM3 concentration (nM) over time in serum as a target engagement biomarker (N=30). ( B ) CD8 T-cell density, antigen processing and cytotoxicity gene signatures at baseline and EOC1 (N=19). ( C ) IHC and transcriptomic profiling biomarker changes on treatment (N=19). ( D ) IHC and transcriptomic profiling biomarker assessment at screening (N=25). Ag, antigen; BOR, best overall response; CPS, combined positive score; EOC1, end of cycle 1; IHC, immunohistochemistry; PD, progressive disease; PR, partial response; SD, stable disease; TIM-3, T-cell immunoglobulin and mucin-domain containing 3; TIS, tumor inflammation signature; TLS, tertiary lymphoid structure.

Journal: Journal for Immunotherapy of Cancer

Article Title: Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer

doi: 10.1136/jitc-2025-012344

Figure Lengend Snippet: Pharmacodynamic effects of combination treatment (Sym021+S095018) on immune-related markers. ( A ) Total soluble TIM3 concentration (nM) over time in serum as a target engagement biomarker (N=30). ( B ) CD8 T-cell density, antigen processing and cytotoxicity gene signatures at baseline and EOC1 (N=19). ( C ) IHC and transcriptomic profiling biomarker changes on treatment (N=19). ( D ) IHC and transcriptomic profiling biomarker assessment at screening (N=25). Ag, antigen; BOR, best overall response; CPS, combined positive score; EOC1, end of cycle 1; IHC, immunohistochemistry; PD, progressive disease; PR, partial response; SD, stable disease; TIM-3, T-cell immunoglobulin and mucin-domain containing 3; TIS, tumor inflammation signature; TLS, tertiary lymphoid structure.

Article Snippet: The samples were sent to Veracyte for multiplex immunohistochemistry (IHC) and gene expression profiling analysis (NanoString).

Techniques: Concentration Assay, Drug discovery, Biomarker Discovery, Immunohistochemistry